Peter D. Le

Array ( [id] => 1414871 [patent_doc_number] => 06518063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Osf2/Cbfa1 nucleic acids and methods of use therefor' [patent_app_type] => B1 [patent_app_number] => 09/086663 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 54 [patent_no_of_words] => 79477 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518063.pdf [firstpage_image] =>[orig_patent_app_number] => 09086663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420701 [patent_doc_number] => 06503499 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Viral vector complexes having adapters of predefined valence' [patent_app_type] => B1 [patent_app_number] => 09/079882 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9764 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503499.pdf [firstpage_image] =>[orig_patent_app_number] => 09079882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4358071 [patent_doc_number] => 06218528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'MurB' [patent_app_type] => 1 [patent_app_number] => 9/078691 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21830 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218528.pdf [firstpage_image] =>[orig_patent_app_number] => 078691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5991136 [patent_doc_number] => 20020100066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'NEGATIVE STRAND RNA VIRAL VECTOR HAVING AUTONOMOUS REPLICATION CAPABILITY' [patent_app_type] => new [patent_app_number] => 09/070938 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10055 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20020100066.pdf [firstpage_image] =>[orig_patent_app_number] => 09070938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365494 [patent_doc_number] => 06566093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Alphavirus cDNA vectors' [patent_app_type] => B1 [patent_app_number] => 09/061912 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 4833 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566093.pdf [firstpage_image] =>[orig_patent_app_number] => 09061912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130232 [patent_doc_number] => 06146894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Method for generating hypermutable organisms' [patent_app_type] => 1 [patent_app_number] => 9/059461 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 11384 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146894.pdf [firstpage_image] =>[orig_patent_app_number] => 059461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429059 [patent_doc_number] => 20020127204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'IMPROVEMENTS IN OR RELATING TO PROTECTION AGAINST INTRACELLULAR INFECTION' [patent_app_type] => new [patent_app_number] => 09/051393 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127204.pdf [firstpage_image] =>[orig_patent_app_number] => 09051393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4161035 [patent_doc_number] => 06156952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'HIV transgenic animals and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/058113 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16228 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156952.pdf [firstpage_image] =>[orig_patent_app_number] => 058113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643687 [patent_doc_number] => 06429353 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Endometriosis mouse model' [patent_app_type] => B1 [patent_app_number] => 09/047910 [patent_app_country] => US [patent_app_date] => 1998-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4182 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429353.pdf [firstpage_image] =>[orig_patent_app_number] => 09047910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787534 [patent_doc_number] => 20030138773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'METHODS OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION' [patent_app_type] => new [patent_app_number] => 09/047966 [patent_app_country] => US [patent_app_date] => 1998-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 14705 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138773.pdf [firstpage_image] =>[orig_patent_app_number] => 09047966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549833 [patent_doc_number] => 06399328 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Methods and compositions for diagnosis and treatment of breast cancer' [patent_app_type] => B1 [patent_app_number] => 09/044781 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 26147 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399328.pdf [firstpage_image] =>[orig_patent_app_number] => 09044781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093230 [patent_doc_number] => 06133502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Monocyte chemoattractant protein and its receptor transgenic animal' [patent_app_type] => 1 [patent_app_number] => 9/037327 [patent_app_country] => US [patent_app_date] => 1998-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 12126 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133502.pdf [firstpage_image] =>[orig_patent_app_number] => 037327 [rel_patent_id] =>[rel_patent_doc_number] =>)